Noriaki Tatsuta

Title: Noriaki Tatsuta: Innovator in Pharmaceutical Patents

Introduction

Noriaki Tatsuta, based in Lexington, MA, is a notable inventor with a remarkable portfolio of 22 patents. His contributions to the field of pharmaceuticals emphasize innovative advancements that address significant medical challenges, particularly in cancer treatment.

Latest Patents

Among his latest patents, Tatsuta has developed **Paclitaxel enhancer compounds**, which are crucial for enhancing the efficacy of Paclitaxel, a commonly used chemotherapeutic agent. This patent includes a compound represented by a specific structural formula along with pharmaceutical compositions that can facilitate its use alongside Paclitaxel or its analogs to treat cancer effectively. Another notable patent is for **Oral formulations of bis(thiohydrazide amides)**, which provides formulations that can offer effective therapeutic benefits for various conditions. The patent outlines the structural formula of these compounds, enhancing their applicability in medicinal formulations.

Career Highlights

Noriaki Tatsuta's career includes significant roles at innovative companies such as Synta Pharmaceuticals Corporation. His work at Synta focused on developing groundbreaking pharmaceutical solutions that leverage his patents' unique properties.

Collaborations

Throughout his career, Tatsuta has collaborated with esteemed colleagues such as Keizo Koya and Lijun Sun. These partnerships have fostered an environment conducive to developing innovative therapeutic solutions, enriching the pharmaceutical landscape.

Conclusion

Noriaki Tatsuta's dedication to innovation in pharmaceuticals is evident through his substantial patent portfolio and collaborative efforts. His work not only propels advancements in cancer treatment but also illustrates the vital role inventors play in transforming scientific research into practical solutions for healthcare challenges.